1. Home
  2. EFOI vs TPST Comparison

EFOI vs TPST Comparison

Compare EFOI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Focus Inc.

EFOI

Energy Focus Inc.

HOLD

Current Price

$1.91

Market Cap

10.2M

ML Signal

HOLD

Logo Tempest Therapeutics Inc.

TPST

Tempest Therapeutics Inc.

HOLD

Current Price

$2.19

Market Cap

11.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFOI
TPST
Founded
1985
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.2M
11.1M
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
EFOI
TPST
Price
$1.91
$2.19
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
11.4K
54.0K
Earning Date
03-20-2026
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.47
EPS
N/A
N/A
Revenue
$4,860,000.00
$295,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.43
$0.60
52 Week High
$3.56
$12.22

Technical Indicators

Market Signals
Indicator
EFOI
TPST
Relative Strength Index (RSI) 48.42 41.83
Support Level $1.71 $2.14
Resistance Level $1.89 $2.49
Average True Range (ATR) 0.15 0.12
MACD 0.02 0.01
Stochastic Oscillator 37.76 29.07

Price Performance

Historical Comparison
EFOI
TPST

About EFOI Energy Focus Inc.

Energy Focus Inc engages in the design, development, manufacturing, marketing, and sale of energy-efficient lighting systems and controls. The company serves the military maritime market and general commercial markets. Its product offerings include Military maritime LED lighting products such as military intelligible, globe lights, berth lights, and military fixtures and Commercial products such as LED fixtures and panels, LED down-lights, LED dock lights, and LED retrofit kits. Geographically, it operates in the United States and other countries. Its products include commercial products and MMM products. The company generates a majority of its sales from Military maritime products in the United States.

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Share on Social Networks: